• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Hyderus

Hyderus Cyf and Hyderus Teoranta

Pandemicast
  • Home
  • Tell the Truth
    • Videos
  • About us
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Sitemap

Pages

  • About us
    • Mark Chataway
    • New Work in India
    • Our approach to managing risk perception and crises
    • We pay our taxes
  • Access to innovative medicines
  • African journalists we respect
  • Cookie Policy
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Flexible Pricing Plan
  • News
  • Our World
  • Our world
  • Our world
  • Partners
  • Privacy Policy (GDPR)
  • Sitemap
  • St Tudors – Press Kit
  • Stop the HAZREM permit – Press Kit
  • Tell the Truth
    • Hyderus – The Three Commitments
    • Videos
  • Terms of use
  • Want to write for us? Got a story for us?
  • Ways to contact Hyderus
    • Job Vacancies
  • What we do

Posts

  • The Hyderus Chronicles: Welcome to the Hyderus blog!
  • Lessons from the candy store and the playground: how to defend government spending in hard times
  • How come people in international development have not noticed the age of austerity?
  • A Development Dilemma
  • Let us have an agency pitch
  • The way out of the maze for the pharmaceutical industry
  • Bleak outlook for development assistance in 2012
  • Pharmas intimacy problem with social media
  • The Hyderus Chronicles: Take a quick office tour and meet our team!
  • The Hyderus Chronicles: A typical day at the office in Cwmfelinfach
  • Welsh Dimension 1
  • The Hyderus Chronicles: The Welsh Dimension (II)
  • The Hyderus Chronicles: The Welsh Dimension (III)
  • The Hyderus Chronicles: St. Davids Day
  • Is The Indian foreign policy too feeble to let it lead?
  • Indian patients demand non-Ranbaxy medicines
  • Innovation in health: New method uses clays to grow human bones
  • Do cash transfer schemes work? Study by SEWA and UNICEF shows they do
  • Is The Indian family planning policy coercive and abusive?
  • Indian media pack turns on the worlds largest generic producer
  • Award-winning spot on domestic violence
  • Low-cost devices developed to reduce maternal mortality in India
  • How not to handle a problem – look to HPV vaccines in Japan
  • Brazils street protesters demand more spending on health
  • When the powerful complain, editors usually roll over. Not on this vaccines story
  • Are negotiations with the Taliban really just surrender talks?
  • Mum, why did I have to get cervical cancer? “There was a vague sense of controversy about the vaccine”
  • Is President Obama hypocritical on climate change?
  • Multinational pharma goes on the offensive against Indian generics
  • Are university frauds threatening the UK’s research standing?
  • 11 billion people? No problem
  • International thinktank calls for backroom deals between regulators, payers and pharma
  • Vitamin supplements kill but get $27 billion a year in US consumer spending
  • Orwell lives in UK gov’t: ODA progress is either “good”, “satisfactory” or … blank
  • How South Africa is beating the AIDS epidemic
  • What happens to the Gulf if the US doesn’t need its oil?
  • Sue and get better: Brazil’s patchy health system explained
  • British overseas development spending grows amidst cuts — as we predicted
  • Big London meeting on the rôle of killing in partnerships for global health – blog
  • Are we losing the fight for women’s health?
  • How come the year’s best writing on cancer among poor women in India is from Forbes?
  • Why being anxious will help you cope with life
  • How Syria looks from Syria
  • The WHO’s narrow vision of the private sector is alarming
  • Brazil: was it Occupy or something longer lasting?
  • Why do UK governments invest in global public health? Academic paper contains nuggets
  • The background in Egypt: two good listens
  • Anti-vaccine crazies back on the attack despite US HPV figures
  • MERS: two surgeons call for checks on Hajj travellers, thoughtful writing on bugs jumping species
  • Is India’s foreign policy feeble or wise?
  • BRICS co-operation on health: where’s the beef?
  • Nudges work better than penalties in US healthcare market
  • Which country in Africa has the highest per capita GDP? (And 80% poverty)
  • Gates Foundation boldly invests where no foundation has invested before – @gateshealth
  • New treatments may cripple bacteria by stopping them from socialising
  • $33 billion for supplements that kill but we expect others to pay for medicines
  • Harvard: megatrends in healthcare (it’s all … dull)
  • Lancet unfair about Russia’s new role as global donor, history with AIDS
  • Which big country has very high child mortality and is upper middle income?
  • Bye bye BRICS say investors
  • Clinical trials often don’t answer real-life questions
  • An insider’s view of what India and the USA really talked about in June
  • Arrests of GSK execs in China maybe linked to push for lower prices
  • Anti-vaccine fanatic gets network TV job
  • Sources of best innovation? South Korea bottom; Russia and India doing well
  • Researchers miss the point on drug price mess in middle income countries
  • Brazil leads the world in digital news
  • Where the poorest live and why there are many fewer of them
  • Recession may be good for health; austerity kills
  • If you think aid changes things, you should move to Afghanistan while you can
  • “Snowden Republicans” confident they can change US foreign policy
  • Slow progress in getting African tax revenues into health
  • Cancer: over-diagnosed and over-treated
  • Antibiotic resistance; “a risk as serious as terrorism”
  • Electricity is the new health in Africa
  • 80 percent of all antibiotics in the US used on farm animals
  • Anaesthesia may double the risk of dementia
  • NCDs and traffic deaths in Africa: fated to remain the poor cousins of infectious disease?
  • Welsh companies do better in India than their English counterparts — look at Hyderus
  • Reactions to the Bongo Bongo Land controversy #aid #development
  • Indian delight over US decision on Samsung #patents – impact on #accesstomedicine
  • Worst clinical trial abuse ever – at a US public university
  • China in Africa isn’t good or bad. It’s a mix — says Chinese gov’t #ChinaAfrica
  • As concerns over governance grow, Clinton Foundation shifts focus to women and children
  • Liconomics: Chinese #greenenergy to grow at twice the rate of general economy
  • When two economists decide to have a child #pregnancy
  • #Rotavirus vaccine protects unimmunised adults
  • How to avoid a stroke: dress shabbily
  • Health decisions: time to confront our denial of the irrational
  • Mobile phones are transforming healthcare in #Africa #africahealth #gavi
  • Germany’s Greens are becoming a party of the rich #green #eco
  • India’s patent system on medicine may be the new normal #accesstomedicine #india
  • America’s bad value healthcare system #publichealth #healthecon
  • Time to retire the IPCC? Nature seems to think so #climatechange
  • Public-private partnerships watch out: audited results might be required #development #syngenta #csr
  • Nodding syndrome a deadly mystery in East Africa #ntd #uganda
  • Keeping ODA at home – some surprising candidates
  • In #Africa, the rich thrive but the poor sink — new survey confirms
  • India may start seizing #patent rights for #greenenergy
  • India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper
  • Where do Iran and the West have shared interests in #Syria? What can’t be discussed in polite conversation
  • South Africa breaks ranks with Brazil, China and India on #climatechange
  • Cervical cancer: large study shows #HPV vaccines have no serious side effects #hpvvaccine
  • China’s first global #vaccine against a backdrop of massive #sciencefraud
  • Imagine telemedicine #Acano
  • What Marriott’s leaked crisis guide tells you
  • Why even good market research is becoming less reliable
  • European governments increasingly wobbly on #climatechange and #greenenergy
  • Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI
  • Girls in Rwanda better protected than girls in the US @GAVISeth #HPV #HPVaccine
  • Reputation in a time of social media dominance and recession
  • Living in an age when images never disappear
  • Don’t waste money on #AIDS counselling, test
  • #Indonesia #universalhealth plan seems destined for failure – BBC documentary
  • Global development policymakers live in a tiny bubble
  • What’s missing from #climatechange talks on #globalwarming? Media
  • Bill Gates “satisfied” with #polio eradication in Nigeria but wishes it were India #GPEI #endpolio
  • #MRSA infections cripple US professional football team #antibiotic resistance
  • The Carbon Crooks — how organised crime took over carbon trading #COP19 #climate change
  • Which rich countries are best and worst in the way they treat poor countries?
  • WHO blocked #Syria #polio campaign for weeks because of regional in-fighting says Spiegel
  • Medicines are never used unless pharma promotes them, says UK’s top left-wing magazine #badpharma
  • Being trendy matters more than making sense in @TheLancet #Palestine
  • The Brits are destroying the moral code of American journalism
  • Business travellers matter more than sick people say developing country governments
  • “The new drug war”: The Economist predicts a long wait for access to medicines
  • An uncomfortable truth: sanctions create dissatisfaction — look at #Gaza for example #Palestine
  • Insurance increases use of emergency rooms says new randomised study
  • Health communications does not change the way anti-vaccine crazies behave
  • Are there too few doctors in the world or are they just work-shy and cosseted?
  • Gŵyl Dewi Sant yn India (the Welsh take over in Delhi)
  • The coming water wars and how bored the media are with climate change
  • Work experience blog by Jessica Jones
  • Brazil’s shortage of doctors becomes a hot political topic
  • Hyderus featured in The Times for policy research in difficult countries
  • Shock finding: very sick people die sooner; very healthy people stay quite healthy
  • Cyhoeddusrwydd i Hyderus wrth ennill cytundeb Indiaidd/ Publicity for Hyderus as it wins Indian Contract
  • More Publicity for Hyderus
  • Britain’s medical press: a tabloid mentality or a tool in bargaining by doctors?
  • Are both sides in the climate change debate being “dirty, nasty and destructive”?
  • Burson Marsteller and David Axelrod linked to high visibility failures
  • Do negative ads really work? Yes. Just not how you thought
  • Who would you trust more, the Kansas City Star or the British Medical Journal? #BMJ
  • What drives Hamas? Fanaticism? Probably it’s understanding opinion polls #Gaza #Palestine
  • UK parliamentary report on R&D for neglected diseases focuses on …. medieval Venice
  • Does bad qualitative research guide US policy?
  • Award-winning spot on gender violence
  • WHO gets interesting on IP
  • Poll: Chinese want action on climate more than Europeans or Americans
  • A few brave psychiatrists speak out for #benzodiazepines
  • Hyderus causing a stink!
  • International declarations and treaties don’t change things — Tweets do
  • The failure of global health advocacy spelled out in numbers
  • Hyderus making bigger waves!!
  • The Addis deal that will “turbo charge development”
  • The basics about spending on health around the world
  • Five myths about access to medicines in emerging markets
  • Hyderus making tidal waves in the world of pharmaceutical journalism!
  • Mark’s five myths about emerging markets made simple!
  • Hyderus – it’s all about Community!
  • Access to advanced medicines and affordability: a look forward to 2016
  • Policy dialogue in the Twitter age
  • India’s new medicine taxes hit the poor and the sick
  • Media training needs a radical rethink
  • What India will really do about access to innovative medicines
  • Patagonia/Argentina – what’s our connection?
  • The pharma industry’s access Catch-22
  • The dangerous unreliability of quantitative market research seen in Brexit
  • Hype for UN’s report on access to medicines is confused and contradictory
  • Donald Trump’s stance on anti-vaccination
  • Failed trials for Alzheimer’s may mean a key theory is wrong
  • Mosquito-borne illness in 2017
  • Biosimilars and the trastuzumab controversy
  • Trump to remove critical funds from the CDC?
  • A few more months for a six figure sum, the ethics of cancer medications
  • The Human Development Index, what makes a country great?
  • Pharmaceutical research: the price of failure
  • Development aid to poorest nations falling in favour of domestic spending on refugees
  • Measles outbreaks in Europe: anti-vaccination movement to blame?
  • Developing nations going against trend of tobacco decline
  • HIV treatment, CRISPR/cas9 and the safety of gene editing
  • Tedros Adhanom Ghebreyesus, new WHO director-general
  • Flu vaccine efficacy, a genetic uphill battle
  • Mexico City Policy: Putting the US at odds with the EU?
  • Trump withdraws from the Paris Agreement – global reaction
  • The “post-antibiotic apocalypse”
  • Global Fund welcomes Peter Sands as new Executive Director
  • FDA shelf lives driving up the cost of healthcare
  • Vaccination laws in EU nations set to cause conflict?
  • Amazon to join the pharmaceutical market?
  • Ambitious goals for UK Pharma, does the budget match up?
  • The continued fight against polio
  • Drug resistant HIV and the potential to render current treatments inviable
  • Immunotherapy: the future of Alzheimer’s research?
  • Robotic takeover of healthcare on the horizon?
  • Axovant fails while Pfizer leaves – the grim outlook of Alzheimer’s research
  • New hope for Huntington’s disease?
  • Brexit: A boon for Big Tobacco?
  • Indian patent laws, no longer the pharmacy of the developing world?
  • TB ‘miracle cures’ and the issue of high expectations
  • Blood test to detect early stage cancer
  • Hyderus participates in study on whether EU funding has helped people with poverty related diseases
  • Brexit uncertainty, blocking both medicines and migrants?
  • US malaria donations saving two million children?
  • Climate Change Forcing Nursing Industry to Reassess Practice and Policies
  • Anti-vaccination movement show the damage conspiracy theories can do
  • New strains of TB threaten to bypass current diagnostics
  • The global gag rule does not stop abortions. It does the opposite.
  • Parkinson’s and the difficulty of treating neurological conditions
  • Vaccine Hesitancy – One of the world’s top 10 global health threats
  • Disease epidemiology in the world’s newest megacities
  • Business continuity in the era of a global virus pandemic
  • PandemiCast I: Public policy in a pandemic
  • PandemiCast II: The effect on the media
  • PandemiCast III: The search for a vaccine
  • PandemiCast IV: How coronavirus affects other conditions
  • PandemiCast V: An update on public policy
  • PandemiCast VI: Sexual and reproductive health
  • PandemiCast VII: The importance of healthcare communications
  • PandemiCast VIII: Sexual and reproductive health (II)
  • PandemiCast IX: Epidemiological models amidst COVID-19
  • PandemiCast X: Public policy in a pandemic (3)
  • PandemiCast X: Public policy (3)
  • PandemiCast XI: International Day of the African Child
  • PandemiCast XII: How coronavirus has hit businesses and what the situation looks like going forward
  • PandemiCast XIII: How COVID has hit HIV
  • PandemiCast XIV: Why we need to pay attention to telehealth and telemedicine
  • Russia’s coronavirus vaccine: The controversy, explained
  • PandemiCast XV: A look at COVID-19 in Africa (Trailer)
  • PandemiCast XV, Part I: The view from Africa
  • PandemiCast XV, Part II: The view from Africa
  • Vaccines and COVID-19: Frans van den Boom speaks to Hyderus and Baird’s CMC
  • Climate change impact has the potential to regress cancer progress through healthcare disruption, according to study
  • Accessible healthcare could aid climate crisis in rainforest communities

Archives

  • December 2020 (2)
  • November 2020 (1)
  • September 2020 (2)
  • August 2020 (2)
  • July 2020 (2)
  • June 2020 (4)
  • May 2020 (9)
  • March 2020 (1)
  • August 2019 (1)
  • July 2019 (1)
  • June 2019 (3)
  • May 2019 (2)
  • June 2018 (1)
  • May 2018 (1)
  • April 2018 (2)
  • March 2018 (4)
  • February 2018 (4)
  • January 2018 (4)
  • December 2017 (1)
  • November 2017 (2)
  • October 2017 (1)
  • September 2017 (2)
  • August 2017 (1)
  • June 2017 (1)
  • May 2017 (4)
  • April 2017 (3)
  • March 2017 (2)
  • February 2017 (2)
  • September 2016 (1)
  • June 2016 (2)
  • May 2016 (1)
  • March 2016 (1)
  • February 2016 (3)
  • January 2016 (1)
  • August 2015 (3)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • March 2015 (1)
  • November 2014 (1)
  • October 2014 (1)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (2)
  • May 2014 (1)
  • April 2014 (5)
  • March 2014 (5)
  • January 2014 (3)
  • December 2013 (3)
  • November 2013 (12)
  • October 2013 (13)
  • September 2013 (10)
  • August 2013 (12)
  • July 2013 (32)
  • June 2013 (29)
  • February 2013 (1)
  • October 2012 (1)
  • September 2012 (2)
  • August 2012 (2)
  • July 2012 (1)
  • January 2012 (1)
  • March 2011 (2)
  • November 2010 (1)
  • June 2010 (1)
  • May 2010 (2)

Categories

  • Featured
  • Our craft
  • Staff blog

Share this:

  • Email
  • Print
  • Facebook
  • Twitter
  • LinkedIn

Primary Sidebar

Categories

  • Featured (206)
  • Our craft (22)
  • Staff blog (56)
access to medicines Africa Chris Nial climate change communications consultancy coronavirus COVID-19 Development Donald Trump environment foreign policy Global Health Progress global warming green energy health healthcare health policy HIV Hyderus india Mark Chataway ODA PandemiCast patents pharmaceutical industry public health vaccination vaccines wales WHO

Hyderus on Twitter

Tweets by Hyderus

Hyderus on Facebook

Videos

The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
More videos

Clients

 
 
 

Footer

Looking For?

  • Our World
  • Contact us
  • Privacy Policy
  • Terms of use

Recent Posts

  • Accessible healthcare could aid climate crisis in rainforest communities
  • Climate change impact has the potential to regress cancer progress through healthcare disruption, according to study
  • Vaccines and COVID-19: Frans van den Boom speaks to Hyderus and Baird’s CMC

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Copyright © 2021 Hyderus. All rights reserved. Sitemap

  • Home
  • Tell the Truth
    ▼
    • Videos
  • About us
    ▼
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    ▼
    • Development and Politics
      ▼
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      ▼
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      ▼
      • Drivers and barriers for new vaccines
    • Strategic Planning
      ▼
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      ▼
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    ▼
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.

Cookies

This site uses cookies: Find out more.